19 November 2024 Purdue University and Akston Biosciences Bring “First Dose of Hope” in New Cancer Immunotherapy Trial for Dogs with Urinary Bladder Cancer
20 August 2024 Energesis and Akston Biosciences Sign Partnership Agreement for Companion Animal Obesity Drug Development
13 August 2024 Purdue and Akston Biosciences Sign Partnership Agreement for Dog Cancer Drug Development
11 March 2024 Akston Biosciences’ AKS-107 Study Published in Frontiers in Immunology, Displaying Ambifect® Platform’s Versatility
26 February 2024 Akston Biosciences’ AKS-452 Vaccine Study Published in Nature, Showcasing Ambifect® Platform’s Versatility
